Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors (Q39376795)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

11 September 2017

Small molecule antibody targeting HLA class I inhibits myeloma cancer stem cells by repressing pluripotency-associated transcription factors (English)

1 reference

Europe PubMed Central

11 September 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

neoplastic stem cells

1 reference

based on heuristic

inferred from title

author name string

A Ikegame

1

1 reference

Europe PubMed Central

11 September 2017

S Ozaki

2

1 reference

Europe PubMed Central

11 September 2017

D Tsuji

3

1 reference

Europe PubMed Central

11 September 2017

T Harada

4

1 reference

Europe PubMed Central

11 September 2017

S Fujii

5

1 reference

Europe PubMed Central

11 September 2017

S Nakamura

6

1 reference

Europe PubMed Central

11 September 2017

H Miki

7

1 reference

Europe PubMed Central

11 September 2017

A Nakano

8

1 reference

Europe PubMed Central

11 September 2017

K Kagawa

9

1 reference

Europe PubMed Central

11 September 2017

K Takeuchi

10

1 reference

Europe PubMed Central

11 September 2017

M Abe

11

1 reference

Europe PubMed Central

11 September 2017

K Watanabe

12

1 reference

Europe PubMed Central

11 September 2017

M Hiasa

13

1 reference

Europe PubMed Central

11 September 2017

N Kimura

14

1 reference

Europe PubMed Central

11 September 2017

Y Kikuchi

15

1 reference

Europe PubMed Central

11 September 2017

A Sakamoto

16

1 reference

Europe PubMed Central

11 September 2017

K Habu

17

1 reference

Europe PubMed Central

11 September 2017

M Endo

18

1 reference

Europe PubMed Central

11 September 2017

K Itoh

19

1 reference

Europe PubMed Central

11 September 2017

H Yamada-Okabe

20

1 reference

Europe PubMed Central

11 September 2017

T Matsumoto

21

1 reference

Europe PubMed Central

11 September 2017

publication date

20 March 2012

1 reference

Europe PubMed Central

11 September 2017

1 reference

Europe PubMed Central

11 September 2017

26

1 reference

Europe PubMed Central

11 September 2017

9

1 reference

Europe PubMed Central

11 September 2017

2124-2134

1 reference

Europe PubMed Central

11 September 2017

https://scigraph.springernature.com/pub.10.1038/leu.2012.78

0 references

Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Improved survival in multiple myeloma and the impact of novel therapies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Characterization of clonogenic multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Multiple myeloma cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Primary Bioassay of Human Myeloma Stem Cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Side population cells in human cancers

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

ABCG2 expression, function, and promoter methylation in human multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Stem cells, cancer, and cancer stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

A role for Wnt signalling in self-renewal of haematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Hedgehog signalling in cancer formation and maintenance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Illegitimate WNT signaling promotes proliferation of multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Targeting the beta-catenin/TCF transcriptional complex in the treatment of multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Core transcriptional regulatory circuitry in human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Wnt signaling promotes reprogramming of somatic cells to pluripotency

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Killing tumor cells through their surface beta(2)-microglobulin or major histocompatibility complex class I molecules

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

2D7 diabody bound to the alpha2 domain of HLA class I efficiently induces caspase-independent cell death against malignant and activated lymphoid cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

A single-chain Fv diabody against human leukocyte antigen-A molecules specifically induces myeloma cell death in the bone marrow environment

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Induction of HM1.24 peptide-specific cytotoxic T lymphocytes by using peripheral-blood stem-cell harvests in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Anti beta2-microglobulin monoclonal antibodies induce apoptosis in myeloma cells by recruiting MHC class I to and excluding growth and survival cytokine receptors from lipid rafts

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Wnt signalling in stem cells and cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Regulation of self-renewal and pluripotency by Sox2 in human embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

SOX2 is frequently downregulated in gastric cancers and inhibits cell growth through cell-cycle arrest and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

A parallel circuit of LIF signalling pathways maintains pluripotency of mouse ES cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Molecular coupling of Tsix regulation and pluripotency

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

The Polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

The cancer stem cell: premises, promises and challenges

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Bone marrow stromal cells from myeloma patients support the growth of myeloma stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Lipid rafts play an important role for maintenance of embryonic stem cell self-renewal

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Telomerase inhibition targets clonogenic multiple myeloma cells through telomere length-dependent and independent mechanisms

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

21 January 2018

Presence of Hoechst low side populations in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.78

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2012.78

1 reference

Europe PubMed Central

11 September 2017

1 reference

Europe PubMed Central

11 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39376795&oldid=1823545944"